ID   HEV0295
AC   CVCL_T210
DR   RCB; HEV0295
DR   Wikidata; Q54883110
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*02:01,26:03; B*40:01,40:02; C*15:02; DPB1*02:01,04:02; DQB1*05:02,06:01; DRB1*08:03,14:54 (RCB=HEV0295).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
RX   PubMed=16260175; DOI=10.1016/j.mrgentox.2005.07.012;
RA   Iwakawa M., Goto M., Noda S., Sagara M., Yamada S., Yamamoto N.,
RA   Kawakami Y., Matsui Y., Miyazawa Y., Yamazaki H., Tsuji H., Ohno T.,
RA   Mizoe J., Tsujii H., Imai T.;
RT   "DNA repair capacity measured by high throughput alkaline comet assays
RT   in EBV-transformed cell lines and peripheral blood cells from cancer
RT   patients and healthy volunteers.";
RL   Mutat. Res. 588:1-6(2005).
//
RX   PubMed=38639832; DOI=10.1007/s13577-024-01055-0; PMCID=PMC11194210;
RA   Kasai F., Fukushima M., Miyagi Y., Nakamura Y.;
RT   "Genetic diversity among the present Japanese population: evidence
RT   from genotyping of human cell lines established in Japan.";
RL   Hum. Cell 37:944-950(2024).
//